For immediate release
September, 2007

Principal Investigator:
Ivar Meyvantsson, PhD
BellBrook Labs
5500 Nobel Drive, Suite 250
Madison, WI 53711
866-313-7881
ivar.meyvantsson@bellbrooklabs.com

BellBrook Labs awarded an NHLBI SBIR Phase I Grant toward developing devices for High Throughput Cell Migration Assays  

The National Heart Lung and Blood Institute has awarded BellBrook Labs, in collaboration with Anna Huttenlocher's laboratory at the University of Wisconsin-Madison, a $300,000 Phase I Small Business Innovative Research grant (R43 HL88785) toward developing devices for high throughput cell migration assays.

The migration of cells from the bloodstream to sites of injury is one of the fundamental processes underlying chronic inflammatory disorders such as arthritis and inflammatory bowel disease. Responding cells migrate toward higher concentrations of signaling molecules that are released at the injury site. To enable the discovery of drugs to block this process, BellBrook Labs is developing plastic devices for high throughput cell migration assays in defined chemical gradients.

BellBrook Labs develops high throughput screening tools that accelerate the discovery of more effective therapies. The microconduit array technology is a line of unique microscale devices that allow easy miniaturization and automation of complex biological assays.

Contact us at 866.313.7881 or info@bellbrooklabs.com for more information or to order the Transcreener UGT Far Red Assay.

Biology at Work